PTC (PTC)

Technology

Atlantic Equity Research

This damning 30-page report by Joe Gagan argues that PTC's management have made multiple material misstatements about their business - Joe argues that investors have been misled about the market acceptance and capabilities of its growth products and management have used the change to a new revenue recognition rule and the change to a new subscription billing method to cover up its real results. He sees similarities to recent cases brought by the SEC against Theranos, Nikola and Under Armour. TP $49 (50%+ downside).

- 26 November, 2021